Charles Anthony Laranjeira

Insider Reports History

Entity
Individual
Location
C/O Pacira Pharmaceuticals, Inc., 5 Sylvan Way, Suite 300, Parsippany, NJ
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Anthony Laranjeira:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Chief Technical Officer Common Stock 41.8K $1.34M $32.00 Jun 14, 2022 Direct
Pacira BioSciences, Inc. Chief Technical Officer Stock Option (Right to Buy) 9K Jun 14, 2022 Direct

Insider Reports Filed by Charles Anthony Laranjeira

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCRX Pacira BioSciences, Inc. Jun 14, 2022 2 $230K 4 Jun 16, 2022 Chief Technical Officer
PCRX Pacira BioSciences, Inc. Jun 6, 2022 7 -$468K 4 Jun 8, 2022 Chief Technical Officer
PCRX Pacira BioSciences, Inc. Nov 22, 2021 2 $331K 4 Nov 24, 2021 Chief Technical Officer
PCRX Pacira BioSciences, Inc. Jun 9, 2021 2 $0 4 Jun 11, 2021 Chief Technical Officer
PCRX Pacira BioSciences, Inc. Jun 4, 2021 1 -$129K 4 Jun 8, 2021 Chief Technical Officer